Company intelligence / Profile preview

Ascend BioVentures

Oklahoma City, Oklahoma, United Statesascendbioventures.com ↗

Ownership: Private
Development stage: Other

Overview

Ascend BioVentures is a pharmaceutical accelerator that identifies innovative therapeutics and launches or supports early-stage companies focused on preclinical drug development. It provides management expertise, advisory committee input from industry leaders, and leverages resources from its parent organization i2E. Its model emphasizes flexibility—sometimes advancing assets without forming new companies—and has supported programs such as small molecules targeting estrogen receptor beta for remyelination in multiple sclerosis. Clinical results are at the preclinical stage; no late-stage clinical data reported publicly.

Therapeutic areas: Neurology
Modalities: Small molecule
Industry: Investors

Partnerships

Plains Ventures

Beyond the preview

Go deeper on Ascend BioVentures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ascend BioVentures.

Explore the full profile